Improved Outcomes with Linezolid for Methicillin-Resistant Staphylococcus aureus Infections: Better Drug or Reduced Vancomycin Susceptibility?

相似書籍

• Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
  由: Howden, Benjamin P., et al.
  出版: (2010)
• 1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
  由: Saravolatz, Louis D, et al.
  出版: (2019)
• Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
  由: Horne, K. C., et al.
  出版: (2009)
• Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
  由: Lin, Chien-Yu, et al.
  出版: (2018)
• Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
  由: Chien-Yu Lin, et al.
  出版: (2018-01-01)